Karen L Tubridy Insider Trading $AKBA Akebia Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen L Tubridy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen L Tubridy. Karen L Tubridy is Chief Development Officer in Eleven Biotherapeutics, Inc. ($EBIO) and SVP, Chief Development Officer in Akebia Therapeutics, Inc. ($AKBA).
Karen L Tubridy in Akebia Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L Tubridy: SVP, Chief Development Officer
Holdings: 88,133 shares
Current Value: $870,754
Latest Transaction: Mar 02 2020
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Karen L Tubridy in Akebia Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Option Exercise | A | 8.87 | 85,000 | 753,950 | 85,000 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Sell | S | 8.70 | 3,454 | 30,050 | 84,679 | 88.1 K to 84.7 K (-3.92 %) |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Grant | A | 0.00 | 30,000 | 0 | 88,133 | 58.1 K to 88.1 K (+51.61 %) |
| Apr 12 2019 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Sell | D | 7.70 | 6,075 | 46,778 | 55,324 | 61.4 K to 55.3 K (-9.89 %) |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Payment of Exercise | F | 8.94 | 11,928 | 106,636 | 30,229 | 42.2 K to 30.2 K (-28.29 %) |
| Mar 02 2018 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Option Exercise | A | 14.30 | 25,000 | 357,500 | 25,000 | |
| Mar 02 2018 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Grant | A | 0.00 | 17,500 | 0 | 41,518 | 24 K to 41.5 K (+72.86 %) |
| Feb 23 2017 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Option Exercise | A | 0.00 | 36,500 | 0 | 36,500 | |
| Feb 23 2017 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Grant | A | 0.00 | 23,000 | 0 | 23,000 | 0 to 23 K |
| Dec 02 2016 | AKBA | Akebia Therapeutic ... | Tubridy Karen L | SVP, Chief Developm ... | Option Exercise | A | 8.61 | 130,000 | 1,119,300 | 130,000 |
Page: 1